Depressive disorder is a very frequent and heterogeneous syndrome. Structural imaging techniques offer a useful tool in the comprehension of neurobiological alterations that concern depressive disorder. Altered brain structures in depressive disorder have been particularly located in the prefrontal cortex (medial prefrontal cortex and orbitofrontal cortex, OFC) and medial temporal cortex areas (hippocampus). These brain areas belong to a structural and functional network related to cognitive and emotional processes putatively implicated in depressive symptoms. These volumetric alterations may also represent biological predictors of response to pharmacological treatment. In this context, major findings of magnetic resonance (MR) imaging, in relation to treatment response in depressive disorder, will here be presented and discussed.

Brain Structural Effects of Antidepressant Treatment in Major Depression / N. Dusi, S. Barlati, A. Vita, P. Brambilla. - In: CURRENT NEUROPHARMACOLOGY. - ISSN 1570-159X. - 13:4(2015 Jul), pp. 458-465.

Brain Structural Effects of Antidepressant Treatment in Major Depression

P. Brambilla
Ultimo
2015

Abstract

Depressive disorder is a very frequent and heterogeneous syndrome. Structural imaging techniques offer a useful tool in the comprehension of neurobiological alterations that concern depressive disorder. Altered brain structures in depressive disorder have been particularly located in the prefrontal cortex (medial prefrontal cortex and orbitofrontal cortex, OFC) and medial temporal cortex areas (hippocampus). These brain areas belong to a structural and functional network related to cognitive and emotional processes putatively implicated in depressive symptoms. These volumetric alterations may also represent biological predictors of response to pharmacological treatment. In this context, major findings of magnetic resonance (MR) imaging, in relation to treatment response in depressive disorder, will here be presented and discussed.
amygdala; cingulate; citalopram; doxepine; fluoxetine; fluxovamine; hippocampus; mirtazapine; paroxetine; prefrontal cortex; reboxetine; sertraline; trimipramine; venlafaxine
Settore MED/25 - Psichiatria
lug-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
Dusi-MS_CN 2nd.pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.32 MB
Formato Adobe PDF
1.32 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/437469
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 84
  • ???jsp.display-item.citation.isi??? 79
social impact